X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (49294) 49294
Newspaper Article (5524) 5524
Newsletter (3604) 3604
Magazine Article (355) 355
Book Chapter (201) 201
Government Document (49) 49
Web Resource (47) 47
Trade Publication Article (44) 44
Book / eBook (38) 38
Transcript (28) 28
Book Review (17) 17
Dissertation (17) 17
Paper (9) 9
Reference (7) 7
Publication (5) 5
Conference Proceeding (3) 3
Report (2) 2
Data Set (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37425) 37425
pneumonia (31365) 31365
male (20770) 20770
female (19131) 19131
bacterial pneumonia (13486) 13486
middle aged (12660) 12660
adult (12002) 12002
aged (10515) 10515
anti-bacterial agents - therapeutic use (9405) 9405
infectious diseases (8717) 8717
antibiotics (7583) 7583
infections (7251) 7251
pneumonia - drug therapy (6928) 6928
mortality (6674) 6674
research (6383) 6383
risk factors (5887) 5887
animals (5791) 5791
microbiology (5603) 5603
health aspects (5515) 5515
drug therapy (5477) 5477
treatment outcome (5223) 5223
respiratory system (5162) 5162
care and treatment (4720) 4720
patients (4637) 4637
adolescent (4631) 4631
pharmacology & pharmacy (4532) 4532
child (4472) 4472
retrospective studies (4192) 4192
community-acquired pneumonia (4147) 4147
medicine, general & internal (4050) 4050
immunology (3979) 3979
diagnosis (3855) 3855
aged, 80 and over (3852) 3852
pneumonia, bacterial - drug therapy (3837) 3837
child, preschool (3812) 3812
infant (3622) 3622
hospitals (3543) 3543
analysis (3434) 3434
medical research (3393) 3393
infection (3283) 3283
therapy (3234) 3234
pediatrics (3171) 3171
epidemiology (2996) 2996
drug resistance (2986) 2986
community-acquired infections - drug therapy (2969) 2969
medicine (2811) 2811
disease (2801) 2801
children (2791) 2791
prospective studies (2780) 2780
bacteria (2779) 2779
ventilator-associated pneumonia (2716) 2716
clinical trials (2698) 2698
medicine, experimental (2682) 2682
anti-bacterial agents - administration & dosage (2635) 2635
mice (2613) 2613
management (2599) 2599
microbial sensitivity tests (2596) 2596
critical care medicine (2553) 2553
anti-bacterial agents - pharmacology (2421) 2421
lung diseases (2289) 2289
medicine & public health (2286) 2286
internal medicine (2236) 2236
bacterial infections (2225) 2225
prognosis (2216) 2216
nosocomial infections (2196) 2196
sepsis (2195) 2195
drug therapy, combination (2192) 2192
inflammation (2188) 2188
research article (2176) 2176
studies (2135) 2135
drug resistance in microorganisms (2108) 2108
time factors (2104) 2104
pneumonia, bacterial - microbiology (2066) 2066
abridged index medicus (2000) 2000
pneumonia - etiology (1996) 1996
oncology (1938) 1938
pneumonia, pneumocystis - drug therapy (1933) 1933
young adult (1913) 1913
pneumonia - diagnosis (1902) 1902
risk-factors (1900) 1900
prevention (1899) 1899
pathogens (1890) 1890
hospitalization (1861) 1861
cross infection - drug therapy (1761) 1761
lung - pathology (1761) 1761
adults (1759) 1759
intensive care units (1756) 1756
drug dosages (1735) 1735
pneumonia - microbiology (1734) 1734
diagnosis, differential (1725) 1725
drugs (1696) 1696
respiratory tract diseases (1676) 1676
aids (1671) 1671
surgery (1641) 1641
cancer (1621) 1621
incidence (1613) 1613
usage (1608) 1608
dosage and administration (1599) 1599
antimicrobial agents (1592) 1592
infant, newborn (1591) 1591
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (17) 17
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Circulation Desk (1) 1
Media Commons - Microtexts (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (54325) 54325
Russian (1031) 1031
Japanese (930) 930
German (921) 921
French (813) 813
Spanish (668) 668
Chinese (360) 360
Polish (162) 162
Italian (128) 128
Dutch (103) 103
Danish (77) 77
Portuguese (59) 59
Ukrainian (46) 46
Turkish (43) 43
Romanian (42) 42
Hungarian (41) 41
Swedish (37) 37
Norwegian (28) 28
Korean (23) 23
Czech (20) 20
Finnish (20) 20
Hebrew (19) 19
Croatian (13) 13
Lithuanian (9) 9
Serbian (8) 8
Icelandic (7) 7
Bulgarian (4) 4
Slovak (3) 3
Afrikaans (1) 1
Bosnian (1) 1
Hindi (1) 1
Indonesian (1) 1
Latvian (1) 1
Persian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical microbiology and infection, ISSN 1198-743X, 2018, Volume 24, Issue 12, pp. 1339.e1 - 1339.e5
...) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing... 
Listeria monocytogenes | Listeriosis | Pleural effusion | Immunosuppression | Pneumonia | INFECTIOUS DISEASES | MANAGEMENT | SERIES | SURVEILLANCE | EFFUSION | MICROBIOLOGY | CENTRAL-NERVOUS-SYSTEM | Listeriosis - drug therapy | Sepsis - etiology | Lung Diseases - microbiology | Humans | Middle Aged | Pneumonia, Bacterial - etiology | Male | Lung Diseases - drug therapy | Lung Diseases - etiology | Empyema, Pleural - epidemiology | Listeriosis - epidemiology | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Pleuropneumonia - epidemiology | Aged, 80 and over | Adult | Female | Respiratory Tract Infections - etiology | Retrospective Studies | Pleuropneumonia - drug therapy | Pleuropneumonia - etiology | Pneumonia, Bacterial - microbiology | Listeriosis - complications | Empyema, Pleural - microbiology | Sepsis - epidemiology | Listeria monocytogenes - isolation & purification | Respiratory Tract Infections - drug therapy | Pleuropneumonia - microbiology | Pneumonia, Bacterial - epidemiology | Empyema, Pleural - drug therapy | Listeriosis - microbiology | Pneumonia, Bacterial - drug therapy | Aged | Respiratory Tract Infections - epidemiology | Empyema, Pleural - etiology | Lung Diseases - epidemiology | Sepsis - microbiology | Listeria monocytogenes - drug effects | Pneumonia, Bacterial/etiology | Lung Diseases/epidemiology | Sepsis/drug therapy | Empyema, Pleural/epidemiology | Listeriosis/drug therapy | Sepsis/microbiology | Lung Diseases/microbiology | Pneumonia, Bacterial/epidemiology | Lung Diseases/etiology | Life Sciences | Listeriosis/microbiology | Pneumonia, Bacterial/drug therapy | Sepsis/epidemiology | Pleuropneumonia/epidemiology | Pleuropneumonia/etiology | Respiratory Tract Infections/drug therapy | Lung Diseases/drug therapy | Empyema, Pleural/drug therapy | Listeria monocytogenes/isolation & purification | Pleuropneumonia/drug therapy | Listeria monocytogenes/drug effects | Respiratory Tract Infections/epidemiology | Pleuropneumonia/microbiology | Bacteriology | Human health and pathology | Microbiology and Parasitology | Infectious diseases | Respiratory Tract Infections/etiology | Respiratory Tract Infections/microbiology | Listeriosis/complications | Empyema, Pleural/etiology | Empyema, Pleural/microbiology | Listeriosis/epidemiology | Pneumonia, Bacterial/microbiology | Anti-Bacterial Agents/therapeutic use | Sepsis/etiology
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2016, Volume 15, Issue 3, pp. 270 - 278
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 18, pp. 1671 - 1680
BACKGROUND The benefits of triple therapy for chronic obstructive pulmonary disease (COPD... 
MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | IMPACT | PARALLEL-GROUP | DOUBLE-BLIND | TIOTROPIUM | RANDOMIZED CONTROLLED-TRIAL | FLUTICASONE PROPIONATE/SALMETEROL | SALMETEROL | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Hospitalization - statistics & numerical data | Male | Dyspnea - etiology | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - complications | Muscarinic Antagonists - administration & dosage | Androstadienes - administration & dosage | Intention to Treat Analysis | Quality of Life | Dyspnea - drug therapy | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Treatment outcome | Lung diseases, Obstructive | Care and treatment | Usage | Analysis | Diagnosis | Inhalers | Pneumonia | Acetylcholine receptors (muscarinic) | Glucocorticoids | Lung diseases | Critical care | Fluticasone | Patients | Quality of life | Medicine | Hospitals | Obstructive lung disease | Population | Chronic obstructive pulmonary disease | Drug dosages | Life Sciences | Human health and pathology | Pulmonology and respiratory tract
Journal Article
Journal Article
American journal of respiratory and critical care medicine, ISSN 1535-4970, 2019, Volume 200, Issue 7, pp. e45 - e67
...: The panel addressed 16 specific areas for recommendations spanning questions of diagnostic testing, determination of site of care, selection of initial empiric antibiotic therapy, and subsequent management decisions... 
LOW-RISK PATIENTS | SUSPECTED PNEUMOCOCCAL PNEUMONIA | VENTILATOR-ASSOCIATED PNEUMONIA | CARE-ASSOCIATED PNEUMONIA | BETA-LACTAM MONOTHERAPY | community-acquired pneumonia | RESISTANT STAPHYLOCOCCUS-AUREUS | SPUTUM GRAM STAIN | MILD-TO-MODERATE | pneumonia | RESPIRATORY SYSTEM | CRITICALLY-ILL PATIENTS | patient management | HIGH-DOSAGE AMOXICILLIN | CRITICAL CARE MEDICINE | Community-Acquired Infections - diagnosis | Culture Techniques | United States | Humans | Pneumonia, Pneumococcal - diagnosis | Haemophilus Infections - diagnosis | Anti-Bacterial Agents - therapeutic use | Community-Acquired Infections - drug therapy | Adult | Haemophilus Infections - metabolism | Drug Therapy, Combination | Haemophilus Infections - drug therapy | Pneumonia, Mycoplasma - metabolism | Severity of Illness Index | Chlamydophila Infections - drug therapy | Blood Culture | Chlamydophila Infections - metabolism | Legionellosis - diagnosis | Hospitalization | Legionellosis - drug therapy | Pneumonia, Bacterial - diagnosis | Ambulatory Care | Moraxellaceae Infections - drug therapy | Chlamydophila Infections - diagnosis | Pneumonia, Pneumococcal - metabolism | Antigens, Bacterial - urine | Pneumonia, Staphylococcal - drug therapy | Moraxellaceae Infections - metabolism | Pneumonia, Staphylococcal - diagnosis | Pneumonia, Staphylococcal - metabolism | Sputum | Pneumonia, Bacterial - drug therapy | Legionellosis - metabolism | Pneumonia, Pneumococcal - drug therapy | Radiography, Thoracic | Moraxellaceae Infections - diagnosis | Macrolides - therapeutic use | beta-Lactams - therapeutic use | Pneumonia, Mycoplasma - diagnosis | Pneumonia, Mycoplasma - drug therapy
Journal Article
Pediatrics, ISSN 0031-4005, 02/2013, Volume 131, Issue 2, pp. e629 - e634
... abnormalities in which hydroxocobalamin and folate therapy provided partial immune reconstitution... 
Cobalamin | Megaloblast | Hemolytic uremic syndrome | Folate | Immunodeficiency | folate | DEFECTS | cobalamin | GENE | megaloblast | TRANSCOBALAMIN-II DEFICIENCY | ABNORMALITIES | PEDIATRICS | immunodeficiency | PATIENT | hemolytic uremic syndrome | Peripheral Nervous System Diseases - diagnosis | Leukopenia - diagnosis | Lipid Metabolism, Inborn Errors - genetics | Pneumonia, Pneumocystis - diagnosis | Humans | 3-Hydroxyacyl CoA Dehydrogenases - genetics | Vitamin B 12 - therapeutic use | DNA Mutational Analysis | Sulfadoxine - therapeutic use | Cardiomyopathies - diagnosis | Infant, Newborn | Cardiomyopathies - drug therapy | Mitochondrial Myopathies | Retinitis Pigmentosa - drug therapy | Trimethoprim - therapeutic use | Combined Modality Therapy | Bone Marrow Examination | Sequence Analysis, DNA | Retinitis Pigmentosa - diagnosis | Severe Combined Immunodeficiency - genetics | Pneumonia, Pneumocystis - genetics | Immunization, Passive | Leukopenia - drug therapy | Genetic Carrier Screening | Peripheral Nervous System Diseases - drug therapy | Mitochondrial Trifunctional Protein - deficiency | Anemia, Megaloblastic - genetics | Minor Histocompatibility Antigens | Lipid Metabolism, Inborn Errors - drug therapy | Leukopenia - genetics | Infant | Rhabdomyolysis | Cardiomyopathies - genetics | Anemia, Megaloblastic - diagnosis | Female | Drug Therapy, Combination | Peripheral Nervous System Diseases - genetics | Methylenetetrahydrofolate Dehydrogenase (NADP) - genetics | Hydroxocobalamin - therapeutic use | Pneumonia, Pneumocystis - drug therapy | Severe Combined Immunodeficiency - diagnosis | Lipid Metabolism, Inborn Errors - diagnosis | Severe Combined Immunodeficiency - drug therapy | Retinitis Pigmentosa - genetics | Opportunistic Infections - genetics | Opportunistic Infections - diagnosis | Exome - genetics | Opportunistic Infections - drug therapy | Anemia, Megaloblastic - drug therapy | 3-Hydroxyacyl CoA Dehydrogenases - deficiency | Drug Combinations | Nervous System Diseases | Care and treatment | Gene mutations | Research | Nucleotide sequencing | Diagnosis | Vitamin B12 | Hemolytic-uremic syndrome | DNA sequencing | Pediatrics | Immunology | Vitamin B | Genetics | Mutation | Drug therapy | Metabolism
Journal Article
Blood, ISSN 0006-4971, 01/2008, Volume 111, Issue 2, pp. 566 - 573
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 2012, Volume 104, Issue 2, pp. 93 - 113
With the advent of targeted agents for the treatment of renal cell carcinoma (RCC), overall survival has improved, and patients are being treated continuously... 
TYROSINE KINASE INHIBITORS | CONTROLLED-TRIAL | INTERFERON-ALPHA | SUNITINIB TREATMENT | CANCER-PATIENTS | VENOUS THROMBOEMBOLISM | ONCOLOGY | HEART-FAILURE | DOUBLE-BLIND | EXPANDED ACCESS PROGRAM | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Hypothyroidism - chemically induced | Pneumonia - therapy | Anorexia - therapy | Humans | Drug Eruptions - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Kidney Neoplasms - metabolism | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Weight Loss - drug effects | Benzenesulfonates - adverse effects | Bevacizumab | TOR Serine-Threonine Kinases - antagonists & inhibitors | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Pyrroles - adverse effects | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Everolimus | Hypothyroidism - therapy | Wound Healing - drug effects | Molecular Targeted Therapy - methods | Sirolimus - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Sirolimus - analogs & derivatives | Europe | Gastrointestinal Tract - drug effects | Cardiovascular System - drug effects | Evidence-Based Medicine | Carcinoma, Renal Cell - metabolism | Indoles - adverse effects | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Anorexia - chemically induced | Kidney Neoplasms - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Drugs | Complications and side effects | Care and treatment | Adverse and side effects | Carcinoma, Renal cell | Research | Drug therapy | Antineoplastic agents
Journal Article